Chakma Justin
ARS Pharmaceuticals, Inc. · Chief Business Officer
Chakma Justin is listed in filings as Chief Business Officer at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY). The current snapshot covers public activity from Nov 27, 2024 to Jan 5, 2026. Reported amounts are shown as $359.8K to $459.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1M136.4k shares | SellNov 12, 2025 | $8.86 | $7.46 | |
| $267k30k shares | SellNov 12, 2025 | $8.91 | $7.46 |